What is the survival benefit of central vascular ligation in colon cancer?
Central vascular ligation (CVL) is a surgical technique where blood vessels supplying the colon tumor are tied off at their origin, allowing removal of more lymph nodes and surrounding tissue. The main question is whether this more extensive surgery improves survival compared to standard surgery. Evidence from a large meta-analysis shows that CVL combined with complete mesocolic excision (CME) improves disease-free and overall survival, but some studies find no benefit for right-sided colon cancer and note increased perioperative mortality. The survival benefit appears most relevant for advanced tumors (T3/T4) where central lymph node metastasis is more common.
What the research says
A systematic review and meta-analysis of 11 prospective studies (including 6 randomized trials) with 4,575 patients found that CME with CVL significantly improved disease-free survival (DFS) and overall survival (OS) compared to surgery without CME+CVL, with no significant heterogeneity across studies 4. However, a large Swedish registry study of 2,084 right-sided colon cancer patients found no difference in 3-year OS, DFS, or local recurrence rates between different extents of vascular ligation, and observed increased perioperative mortality (0.8% to 3.6%) with more extended resection 5. Another review notes that central lymph node metastasis occurs in 1-8% of colon cancer patients, most commonly in T3/T4 tumors, and while such metastasis is associated with worse survival, removing those nodes may confer a survival benefit analogous to resecting distant metastases 6. A prospective study of 197 patients undergoing minimally invasive CME for right colon cancer found that selective CVL (D3 lymphadenectomy) was safe with no major vascular injuries, and that all patients with abnormal central nodes on preoperative imaging had those nodes successfully removed 7. The conflicting results suggest that the benefit of CVL may depend on patient selection, tumor stage, and surgical expertise.
What to ask your doctor
- Based on my tumor stage and location, is central vascular ligation recommended for me?
- What is your experience performing CME with CVL, and what are the complication rates at your center?
- How does the potential survival benefit of CVL compare to the increased risk of perioperative complications?
- Would a less extensive lymph node dissection (D2) be appropriate for my case?
- Are there any ongoing trials or newer evidence on CVL that might affect my decision?
This question is drawn from common patient questions about Oncology and answered using cited medical research. We do not provide individualized advice.